U.S. Stem Cell, Inc. Annual Revenues in USD from 2017 to 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: U.S. Stem Cell, Inc. quarterly/annual Revenues history and growth rate from 2017 to 2022.
U.S. Stem Cell, Inc. Revenues for the quarter ending December 31, 2022 was $20K, a 15.3% decline year-over-year.
U.S. Stem Cell, Inc. Revenues for the twelve months ending December 31, 2022 was $82K, a 59.1% decline year-over-year.
U.S. Stem Cell, Inc. annual Revenues for 2022 was $82K, a 59.1% decline from 2021.
U.S. Stem Cell, Inc. annual Revenues for 2021 was $201K, a 27.6% decline from 2020.
U.S. Stem Cell, Inc. annual Revenues for 2020 was $277K, a 91% decline from 2019.

Revenues, Trailing 12 Months (USD)

Revenues, Annual (USD)

Revenues, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2022	$82K	-$119K	-59.1%	Jan 1, 2022	Dec 31, 2022	10-K	2023-04-14
2021	$201K	-$76.3K	-27.6%	Jan 1, 2021	Dec 31, 2021	10-K	2023-04-14
2020	$277K	-$2.8M	-91%	Jan 1, 2020	Dec 31, 2020	10-K/A	2022-07-08
2019	$3.07M	-$3.63M	-54.2%	Jan 1, 2019	Dec 31, 2019	10-K	2021-07-16
2018	$6.7M	+$1.18M	+21.4%	Jan 1, 2018	Dec 31, 2018	10-K	2021-07-16
2017	$5.52M			Jan 1, 2017	Dec 31, 2017	10-K	2019-03-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.